Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: Subgroup analysis of the ECHELON-2 study at 5 years’ follow-up Correspondence

   

Authors:	Domingo-Doménech, E.; Bosi, B.; Illidge, T.; Horwitz, S.; Trümper, L.; Iyer, S.; Advani, R.; Bartlett, N. L.; Christensen, J. H.; Kim, W. S.
Title:	Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: Subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
Abstract:	Trial registration: ClinicalTrials.gov number: NCT01777152 © 2025 Elsevier B.V., All rights reserved.
Keywords:	adult; cancer chemotherapy; treatment outcome; aged; middle aged; major clinical study; prednisone; clinical trial; constipation; mortality; neutropenia; doxorubicin; cancer combination chemotherapy; diarrhea; drug efficacy; follow up; follow-up studies; antineoplastic agent; letter; progression free survival; sensory neuropathy; nausea; randomized controlled trial; vomiting; antineoplastic combined chemotherapy protocols; peripheral neuropathy; cyclophosphamide; vincristine; pathology; peripheral t cell lymphoma; proportional hazards model; multicenter study; recurrent disease; clinical effectiveness; phase 3 clinical trial; drug therapy; microtubule; non-hodgkin lymphoma; log rank test; anaplastic lymphoma kinase; international prognostic index; post hoc analysis; institutional review; lymphoma, large-cell, anaplastic; anaplastic large cell lymphoma; overall response rate; brentuximab vedotin; humans; human; male; female; prognostic assessment
Journal Title:	Blood Cancer Journal
Volume:	15
ISSN:	2044-5385
Publisher:	Nature Publishing Group
Date Published:	2025-08-01
Start Page:	129
Language:	English
DOI:	10.1038/s41408-025-01329-2
PUBMED:	40750774
PROVIDER:	scopus
PMCID:	PMC12317119
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-105012390468&doi=10.1038%2Fs41408-025-01329-2&partnerID=40&md5=b449099dfedbd067faf0f847a5c9eba2
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/228029